spacer
spacer

PDBsum entry 3dbf

Go to PDB code: 
protein ligands links
Transferase PDB id
3dbf

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
261 a.a. *
Ligands
5FR
Waters ×4
* Residue conservation analysis
PDB id:
3dbf
Name: Transferase
Title: Crystal structure of an activated (thr->asp) polo-like kinase 1 (plk1) catalytic domain in complex with compound 562
Structure: Polo-like kinase. Chain: a. Fragment: plk1 kinase domain. Engineered: yes. Mutation: yes
Source: Danio rerio. Zebrafish. Organism_taxid: 7955. Gene: plk1. Expressed in: escherichia coli.
Resolution:
3.20Å     R-factor:   0.234     R-free:   0.275
Authors: R.A.Elling,J.Zhu,K.J.Barr,M.J.Romanowski
Key ref: R.V.Fucini et al. (2008). Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors. Bioorg Med Chem Lett, 18, 5648-5652. PubMed id: 18793847
Date:
31-May-08     Release date:   07-Oct-08    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q4KMI8  (Q4KMI8_DANRE) -  Serine/threonine-protein kinase PLK from Danio rerio
Seq:
Struc:
 
Seq:
Struc:
595 a.a.
261 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.11.21  - polo kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Bioorg Med Chem Lett 18:5648-5652 (2008)
PubMed id: 18793847  
 
 
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors.
R.V.Fucini, E.J.Hanan, M.J.Romanowski, R.A.Elling, W.Lew, K.J.Barr, J.Zhu, J.C.Yoburn, Y.Liu, B.T.Fahr, J.Fan, Y.Lu, P.Pham, I.C.Choong, E.C.VanderPorten, M.Bui, H.E.Purkey, M.J.Evanchik, W.Yang.
 
  ABSTRACT  
 
A series of 2-amino-pyrazolopyridines was designed and synthesized as Polo-like kinase (Plk) inhibitors based on a low micromolar hit. The SAR was developed to provide compounds exhibiting low nanomolar inhibitory activity of Plk1; the phenotype of treated cells is consistent with Plk1 inhibition. A co-crystal structure of one of these compounds with zPlk1 confirms an ATP-competitive binding mode.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20625580 H.Zhong, S.Xin, Y.Zhao, J.Lu, S.Li, J.Gong, Z.Yang, and S.Lin (2010).
Genetic approach to evaluate specificity of small molecule drug candidates inhibiting PLK1 using zebrafish.
  Mol Biosyst, 6, 1463-1468.  
21583923 J.Peng, Z.Han, N.Ma, and S.Tu (2009).
3,6-Dimethyl-1-phenyl-4-(2-thien-yl)-8-(2-thienylmethyl-ene)-5,6,7,8-tetra-hydro-1H-pyrazolo[3,4-b][1,6]naphthyridine.
  Acta Crystallogr Sect E Struct Rep Online, 65, o1109-o1110.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer